Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: Role of reactive oxygen species and regulation by histamine

Blood

Volumn 96, Issue 5, 2000, Pages 1961-1968

  Mellqvist, U H ^a   Hansson, M ^a   Brune, M ^a   Dahlgren, C ^a   Hermodsson, S ^a   Hellstrand, K ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FORMYLMETHIONYLLEUCYLPHENYLALANINE; HISTAMINE; HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE; REACTIVE OXYGEN METABOLITE; RECOMBINANT INTERLEUKIN 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

APOPTOSIS; ARTICLE; CHRONIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; GRANULOCYTE; HUMAN; HUMAN CELL; LEUKEMIA CELL; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL;

EID: 0034284333     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.5.1961.h8001961_1961_1968     Document Type: Article

References (33)

1. Human natural killer cells: Biologic and pathologic aspects
2. Natural killer (NK) cells and their possible roles in resistance against disease
3. The role of autologous natural killer cells in chronic myelogenous leukemia
4. +(dim) natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis
5. Histaminergic regulation of NK cells: Role of monocyte-derived reactive oxygen metabolites
6. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal-transducing zeta molecules and inhibits tumor-specific T cell- and natural killer cell-mediated cytotoxicity
7. Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites
8. Studies on granulocyte functions in patients with chronic myeloid leukemia
9. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome
10. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V
11. Signalling mechanisms and oxidative stress in apoptosis
12. Histamine protects T-cell and natural killer cells against oxidative stress
13. Respiratory burst in human neutrophils
14. Oxygen dependent defense mechanisms of phagocytes
15. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity
16. Bacterial infection induces nitric oxide synthase in human neutrophils
17. Blood histamine in myelogenous leukemia
18. Inhibition of lymphokine-activated killer- and natural killer-mediated cytotoxicities by neutrophils
19. The differential effects of polymorphonuclear leukocyte secretion on human natural killer cell activity
20. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells
21. Human natural killer cells can inhibit clonogenic growth of fresh leukemic cells
22. Lysis of leukemia and lymphoma cells by autologous and allogeneic interferon-activated blood mononuclear cells
23. Anti-leukemia potential of interleukin-2 activated natural killer ceils after bone marrow transplantation for chronic myelogenous leukemia
24. Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation
25. Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha
26. Endogenous lymphokine activated killer cell activity and cytogenetic response in chronic myelogenous leukae mia treated with alpha-interferon
27. Natural killer-cell immunodeficiency in patients with chronic myelogenous leukemia I. Analysis of the defect using monoclonal antibodies HNK-1 (LEU-7) and B73.1
28. Natural killer cells in chronic leukemia. Function and markers
29. Diminished A-LAK cytotoxicity and proliferation accompany disease progression in chronic myelogenous leukemia
30. Adherent lymphokine-activated killer cells in chronic myelogenous leukemia: A benign cell population with potent cytotoxic activity
31. Variable expression of CD3-zeta and associated protein tyrosine kinases in lymphocytes from patients with myeloid malignancies
32. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses
33. Basophilic leukemia and the hypersecretion of gastric acid and pepsin